Plasma levels of matrix metalloproteinase‐9 (MMP‐9) are associated with cognitive performance in patients with schizophrenia

AIM: Matrix metalloproteinase‐9 (MMP‐9) has been shown to modulate synaptic plasticity and may contribute to the pathophysiology of schizophrenia. This study investigated the peripheral levels of MMP‐9 and its association with cognitive functions in patients with schizophrenia to see the possible in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuropsychopharmacol Rep
Autors principals: Kudo, Noriko, Yamamori, Hidenaga, Ishima, Tamaki, Nemoto, Kiyotaka, Yasuda, Yuka, Fujimoto, Michiko, Azechi, Hirotsugu, Niitsu, Tomihisa, Numata, Shusuke, Ikeda, Manabu, Iyo, Masaomi, Ohmori, Tetsuro, Fukunaga, Masaki, Watanabe, Yoshiyuki, Hashimoto, Kenji, Hashimoto, Ryota
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7722656/
https://ncbi.nlm.nih.gov/pubmed/32022478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/npr2.12098
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars